Spears Abacus Advisors LLC lifted its position in Danaher Co. (NYSE:DHR) by 0.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 320,241 shares of the conglomerate’s stock after acquiring an additional 181 shares during the period. Danaher makes up approximately 5.4% of Spears Abacus Advisors LLC’s holdings, making the stock its 4th biggest holding. Spears Abacus Advisors LLC’s holdings in Danaher were worth $42,278,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in DHR. Vanguard Group Inc boosted its stake in Danaher by 1.4% in the third quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock valued at $4,861,338,000 after acquiring an additional 605,018 shares in the last quarter. BlackRock Inc. increased its holdings in Danaher by 0.5% in the fourth quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock valued at $4,499,639,000 after buying an additional 207,468 shares in the last quarter. FMR LLC increased its holdings in Danaher by 1.4% in the fourth quarter. FMR LLC now owns 22,035,846 shares of the conglomerate’s stock valued at $2,272,336,000 after buying an additional 296,095 shares in the last quarter. Northern Trust Corp increased its holdings in Danaher by 0.4% in the first quarter. Northern Trust Corp now owns 8,887,690 shares of the conglomerate’s stock valued at $1,173,352,000 after buying an additional 34,065 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in Danaher by 8.4% in the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock valued at $774,743,000 after buying an additional 583,194 shares in the last quarter. Institutional investors and hedge funds own 78.93% of the company’s stock.
A number of brokerages have issued reports on DHR. Wolfe Research began coverage on shares of Danaher in a report on Thursday, May 30th. They issued an “outperform” rating for the company. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 target price for the company in a report on Tuesday, April 9th. Deutsche Bank increased their target price on shares of Danaher to $130.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Needham & Company LLC reiterated a “buy” rating and issued a $141.00 price target (up from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. Finally, Piper Jaffray Companies began coverage on shares of Danaher in a research report on Tuesday. They issued a “neutral” rating and a $148.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $133.00.
In other news, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the business’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $131.30, for a total value of $24,143,181.40. Following the completion of the sale, the chief executive officer now owns 302,377 shares of the company’s stock, valued at approximately $39,702,100.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of the business’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $129.52, for a total transaction of $247,771.76. Following the completion of the sale, the director now directly owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 453,448 shares of company stock worth $59,724,640. 11.40% of the stock is owned by company insiders.
Shares of DHR traded up $0.75 during mid-day trading on Friday, reaching $140.17. The company had a trading volume of 11,680 shares, compared to its average volume of 2,184,699. The firm has a market cap of $99.35 billion, a PE ratio of 30.97, a price-to-earnings-growth ratio of 2.68 and a beta of 0.95. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $139.48. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. The company had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. Danaher’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business earned $0.99 EPS. As a group, equities research analysts anticipate that Danaher Co. will post 4.77 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.49%. Danaher’s dividend payout ratio (DPR) is presently 15.04%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Story: Bond
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.